|
FAM73A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.53284068665971E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.26110233367172E-11 |
| Normal-vs-Stage2 |
3.18159998347056E-09 |
| Normal-vs-Stage3 |
7.77489184144997E-13 |
| Normal-vs-Stage4 |
2.49367193561056E-12 |
| Stage1-vs-Stage2 |
7.020000E-01 |
| Stage1-vs-Stage3 |
1.553850E-01 |
| Stage1-vs-Stage4 |
1.118830E-01 |
| Stage2-vs-Stage3 |
1.877000E-01 |
| Stage2-vs-Stage4 |
1.100240E-01 |
| Stage3-vs-Stage4 |
6.329600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.97595281750773E-12 |
| Normal-vs-AfricanAmerican |
4.02670000000382E-05 |
| Normal-vs-Asian |
3.53870266422973E-11 |
| Caucasian-vs-AfricanAmerican |
1.037200E-01 |
| Caucasian-vs-Asian |
9.536000E-01 |
| AfricanAmerican-vs-Asian |
1.429580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.0442536552423E-12 |
| Normal-vs-Female |
1.20630172517622E-11 |
| Male-vs-Female |
1.131000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.20240500784053E-11 |
| Normal-vs-Age(41-60Yrs) |
3.95772303818376E-12 |
| Normal-vs-Age(61-80Yrs) |
8.33344504513889E-12 |
| Normal-vs-Age(81-100Yrs) |
4.434600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.379600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.826800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.473200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.100200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.436600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.040400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.583850E-03 |
| Classical-VS-Follicular |
8.059400E-01 |
| Classical-VS-Other |
1.609020E-01 |
| Classical-VS-Normal |
5.32830446431376E-11 |
| Tall-VS-Follicular |
5.861100E-03 |
| Tall-VS-Other |
7.272600E-01 |
| Tall-VS-Normal |
8.17124146124115E-14 |
| Follicular-VS-Other |
1.697980E-01 |
| Follicular-VS-Normal |
5.72469960324895E-10 |
| Other-VS-Normal |
1.622990E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.6490146721776E-12 |
| Normal-vs-N1 |
2.12441175762024E-12 |
| N0-vs-N1 |
7.907900E-02 |
|
|
